Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration announced Tuesday that it has approved expanded use of leucovorin calcium to treat a rare ...

Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...

The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease ...

Add Yahoo as a preferred source to see more of our stories on Google. On Monday, Sept. 22, the U.S. Food and Drug Administration announced the approval of leucovorin calcium tablets for patients with ...

The Food and Drug Administration on Tuesday approved a long-available generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms. Regulators approved the drug for ...

U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after the Food and Drug Administration enlisted GSK to help it fast-track ...

Indication is restricted to CFD-FOLR1 with a confirmed FOLR1 pathogenic variant, encompassing pediatric and adult patients with severe neurodevelopmental and seizure/movement phenotypes. Evidentiary ...

Scientists have learned more about the genetic factors that may underlie double-jointedness, also known as hypermobility, and diseases that affect connective tissue called hypermobile Ehlers-Danlos ...

Parents of autistic kids deserve the best in science and evidence-based medicine ...

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and ...